Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus.
Denes
E
E
Pichon
N
N
Debette-Gratien
M
M
Bouteille
B
B
Gaulier
J M
JM
D001228:Aspergillosis / Q000188:drug therapy / Q000378:metabolism*; D001232:Aspergillus fumigatus / Q000187:drug effects*; D001922:Brain Abscess / Q000378:metabolism* / Q000382:microbiology; D002555:Cerebrospinal Fluid / Q000378:metabolism* / Q000382:microbiology*; D005260:Female; D006801:Humans; D016867:Immunocompromised Host / Q000187:drug effects*; D008875:Middle Aged; D011743:Pyrimidines / Q000493:pharmacokinetics*; D014230:Triazoles / Q000493:pharmacokinetics*; D065819:Voriconazole
D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole